483
Generation Next FertilityGeneration Next Fertility – FDA 483, Jan 12, 2024
Record Details
Generation Next Fertility in New York, NY, was cited for significant deficiencies in its human reproductive tissue operations. The inspection revealed that procedures for determining donor eligibility were inadequate, particularly concerning Zika Virus screening criteria. Additionally, the firm failed to properly screen oocyte donors for communicable disease risks, and donor eligibility records were found to be inaccurate, lacking clear final determination.
View Company Profile
ID · 8921c704-62f6-4a8c-924d-3840f6d7f725
Other documents for Generation Next Fertility
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.